Piper Sandler Downgrades Alpha Tau Medical to Neutral, Maintains Price Target to $5
Benzinga Newsdesk 8 months ago
NewsDowngradesPrice TargetAnalyst Ratings
Piper Sandler analyst Jason Bednar downgrades Alpha Tau Medical (NASDAQ:DRTS) from Overweight to Neutral and maintains the price target from $5 to $5.
Piper Sandler analyst Jason Bednar downgrades Alpha Tau Medical (NASDAQ:DRTS) from Overweight to Neutral and maintains the price target from $5 to $5.